Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and oprozomib

lenalidomide has been researched along with oprozomib in 2 studies

Compound Research Comparison

Studies
(lenalidomide)		Trials
(lenalidomide)		Recent Studies (post-2010)
(lenalidomide)		Studies
(oprozomib)		Trials
(oprozomib)		Recent Studies (post-2010) (oprozomib)
3,5327252,85051548

Protein Interaction Comparison

ProteinTaxonomylenalidomide (IC50)oprozomib (IC50)
Proteasome subunit beta type-11Homo sapiens (human)0.0235
Proteasome subunit alpha type-7Homo sapiens (human)0.0235
Proteasome subunit beta type-1Homo sapiens (human)0.0235
Proteasome subunit alpha type-1Homo sapiens (human)0.0235
Proteasome subunit alpha type-2Homo sapiens (human)0.0235
Proteasome subunit alpha type-3Homo sapiens (human)0.0235
Proteasome subunit alpha type-4Homo sapiens (human)0.0235
Proteasome subunit beta type-8Homo sapiens (human)0.0385
Proteasome subunit beta type-9Homo sapiens (human)0.0235
Proteasome subunit alpha type-5Homo sapiens (human)0.0235
Proteasome subunit beta type-4Homo sapiens (human)0.0235
Proteasome subunit beta type-6Homo sapiens (human)0.0235
Proteasome subunit beta type-5Homo sapiens (human)0.0327
Proteasome subunit beta type-10Homo sapiens (human)0.0235
Proteasome subunit beta type-3Homo sapiens (human)0.0235
Proteasome subunit beta type-2Homo sapiens (human)0.0235
Proteasome subunit alpha type-6Homo sapiens (human)0.0235
Proteasome subunit alpha-type 8Homo sapiens (human)0.0235
Proteasome subunit beta type-7Homo sapiens (human)0.0235

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appel, A1
Moreau, P; Rajkumar, SV1

Other Studies

2 other study(ies) available for lenalidomide and oprozomib

ArticleYear
Drugs: More shots on target.
    Nature, 2011, Dec-14, Volume: 480, Issue:7377

    Topics: Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Clinical Trials as Topic; Drug Resistance, Neoplasm; Glycine; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Oligopeptides; Protease Inhibitors; Pyrazines; Survival Rate; Thalidomide; Threonine

2011
Multiple myeloma--translation of trial results into reality.
    Lancet (London, England), 2016, Jul-09, Volume: 388, Issue:10040

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Boron Compounds; Bortezomib; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Cyclic N-Oxides; Drug Approval; Drug Discovery; Glycine; Humans; Indolizines; Lactones; Lenalidomide; Multiple Myeloma; Oligopeptides; Practice Guidelines as Topic; Pyridinium Compounds; Pyrroles; Thalidomide

2016